FR2758329B1 - Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique - Google Patents

Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique

Info

Publication number
FR2758329B1
FR2758329B1 FR9700379A FR9700379A FR2758329B1 FR 2758329 B1 FR2758329 B1 FR 2758329B1 FR 9700379 A FR9700379 A FR 9700379A FR 9700379 A FR9700379 A FR 9700379A FR 2758329 B1 FR2758329 B1 FR 2758329B1
Authority
FR
France
Prior art keywords
boronic
imidazole
preparation
therapeutic use
butane derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9700379A
Other languages
English (en)
Other versions
FR2758329A1 (fr
Inventor
Gilbert Lassalle
Patrice Bellevergue
Sergio Mallart
Jean Claude Bourbier
Daniel Galtier
Valerie Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9700379A priority Critical patent/FR2758329B1/fr
Publication of FR2758329A1 publication Critical patent/FR2758329A1/fr
Application granted granted Critical
Publication of FR2758329B1 publication Critical patent/FR2758329B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/22Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9700379A 1997-01-16 1997-01-16 Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique Expired - Fee Related FR2758329B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9700379A FR2758329B1 (fr) 1997-01-16 1997-01-16 Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9700379A FR2758329B1 (fr) 1997-01-16 1997-01-16 Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique

Publications (2)

Publication Number Publication Date
FR2758329A1 FR2758329A1 (fr) 1998-07-17
FR2758329B1 true FR2758329B1 (fr) 1999-02-12

Family

ID=9502641

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9700379A Expired - Fee Related FR2758329B1 (fr) 1997-01-16 1997-01-16 Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique

Country Status (1)

Country Link
FR (1) FR2758329B1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329675B2 (en) 2006-10-10 2012-12-11 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8541581B2 (en) 2009-04-07 2013-09-24 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8546564B2 (en) 2009-04-07 2013-10-01 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US9034849B2 (en) 2010-02-03 2015-05-19 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122627B2 (en) 1999-07-26 2006-10-17 Bristol-Myers Squibb Company Lactam inhibitors of Hepatitis C virus NS3 protease
EP1206449A1 (fr) * 1999-07-26 2002-05-22 Bristol-Myers Squibb Company Inhibiteurs lactame de la protease ns3 du virus de l'hepatite c
WO2003105860A1 (fr) 2002-06-14 2003-12-24 Novo Nordisk A/S Utilisation pharmaceutique d'acides boroniques et de leurs esters
EP2282742A1 (fr) 2008-04-09 2011-02-16 Infinity Pharmaceuticals, Inc. Inhibiteurs d'hydrolase d'amide d'acide gras
WO2013053372A1 (fr) * 2011-10-13 2013-04-18 Therabor Pharmaceuticals Inhibiteurs de type acide boronique de bêta-lactamases
CA2963186A1 (fr) * 2014-10-01 2016-04-07 Merck Patent Gmbh Derives d'acide boronique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701951B1 (fr) * 1993-02-24 1995-06-09 Adir Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2718451B1 (fr) * 1994-04-12 1996-05-10 Synthelabo Dérivés de peptides boroniques, leur préparation et leur application en thérapeutique.
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329675B2 (en) 2006-10-10 2012-12-11 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8349814B2 (en) 2006-10-10 2013-01-08 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8629125B2 (en) 2006-10-10 2014-01-14 Infinty Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US9108989B2 (en) 2006-10-10 2015-08-18 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8541581B2 (en) 2009-04-07 2013-09-24 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8546564B2 (en) 2009-04-07 2013-10-01 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8802119B2 (en) 2009-04-07 2014-08-12 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8802064B2 (en) 2009-04-07 2014-08-12 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US9034849B2 (en) 2010-02-03 2015-05-19 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors

Also Published As

Publication number Publication date
FR2758329A1 (fr) 1998-07-17

Similar Documents

Publication Publication Date Title
NL300295I2 (nl) 3,3-diarylpropylaminen, de toepassing en bereidinghiervan
FR2625743B1 (fr) Derives d'isoquinoleine, leur preparation et leur utilisation
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
FR2758329B1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
IL113332A0 (en) Boronic peptide derivatives, preparation and therapeutic application thereof
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2792318B1 (fr) Derives d'indazole, leur preparation et leur application en therapeutique
FR2753970B1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2752839B1 (fr) Derives de benzofurane, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2753196B1 (fr) Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2741072B1 (fr) Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2769914B1 (fr) Derives d'indazole tricycliques leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
FR2756285B1 (fr) Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
FR2735469B1 (fr) N2-(arylsulfonyl)-l-arginylpiperidin-2-carboxylates, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse